Vast study confirms rare heart risk from Moderna COVID-19 vaccine | Inquirer News
Close  

Vast study confirms rare heart risk from Moderna COVID-19 vaccine

/ 09:45 AM December 17, 2021
Vast study confirms rare heart risk from Moderna COVID-19 vaccine

In this file photo, Registered Nurse Emily Enos loads the Moderna COVID-19 vaccine into a syringe ahead of the distribution of vaccines in the Skid Row area of Downtown Los Angeles, California as the fight against the coronavirus pandemic continues. (Photo by Frederic J. BROWN / AFP)

Paris, France The Moderna COVID-19 jab carries a slight risk of usually non-serious heart problems, a study of the entire population of Denmark found Friday.

Incidences of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) after mRNA jabs from Pfizer and Moderna had been noted in vaccine safety reports and small-scale studies.

ADVERTISEMENT

These reports led France, Denmark, and other countries to advise against the jab for people under 30 years old.

“Vaccination with mRNA-1273 (Moderna) was associated with a significantly increased rate of myocarditis or myopericarditis, especially among individuals aged 12-39 years,” the study said.

FEATURED STORIES

It said that vaccination with Pfizer was only associated with an increased risk among women.

The study published in the BMJ medical journal is the first to look at these side effects in an entire population.

While it confirms the risks, it insists they are slight and that the risks posed by coronavirus infection are greater.

It noted that among the vaccinated who developed myocarditis or pericarditis “only a few” had severe outcomes.

In the case of the 21 people diagnosed with the conditions after receiving Moderna, over half were released from the hospital within 72 hours and none died or were diagnosed with heart failure.

“Our finding of a low absolute risk of myocarditis or myopericarditis with BNT162b2 or mRNA-1273 vaccination supports the overall benefits of such vaccination on an individual, societal, and global level,” the study concluded.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19, Health, Moderna, mRNA, Myocarditis, vaccine, Virus
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.